Gail K. Naughton
2020
In 2020, Gail K. Naughton earned a total compensation of $330.6K as Founder & Chief Scientific Officer at Conatus Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $45,600 |
|---|---|
| Salary | $285,000 |
| Total | $330,600 |
Naughton received $285K in salary, accounting for 86% of the total pay in 2020.
Naughton also received $45.6K in non-equity incentive plan.
Rankings
In 2020, Gail K. Naughton's compensation ranked 11,965th out of 13,090 executives tracked by ExecPay. In other words, Naughton earned more than 8.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,965 out of 13,090 | 9th |
Division Manufacturing | 5,123 out of 5,621 | 9th |
Major group Chemicals And Allied Products | 2,091 out of 2,254 | 7th |
Industry group Drugs | 1,822 out of 1,954 | 7th |
Industry Pharmaceutical Preparations | 1,354 out of 1,459 | 7th |
Source: SEC filing on April 15, 2021.
Naughton's colleagues
We found three more compensation records of executives who worked with Gail K. Naughton at Conatus Pharmaceuticals in 2020.